Skip to main content

Table 2 Univariate and multivariate Cox regression analyses of MACE

From: Relationship between skin autofluorescence levels and clinical events in patients with heart failure undergoing cardiac rehabilitation

Variables Univariate Multivariate
Odds ratio 95% CI P-value Odds ratio 95% CI P-value
SAF 2.00 1.41–2.78 < 0.01 1.86 1.08–3.12 0.03
Age 1.03 1.01–1.05 < 0.01 1.01 0.98–1.04 0.67
BMI 0.90 0.84–0.97 < 0.01 0.88 0.80–0.96 < 0.01
History of CABG 2.24 1.17–4.01 0.02 1.49 0.63–3.38 0.35
Hemoglobin 0.77 0.67–0.87 < 0.01 0.95 0.78–1.15 0.58
Albumin 0.54 0.30–0.96 0.03 1.93 0.86–4.30 0.10
eGFR 0.97 0.96–0.98 < 0.01 0.98 0.97–0.99 0.01
HbA1c 0.94 0.65–1.30 0.73 1.20 0.77–1.79 0.41
Triglyceride 0.99 0.99–1.00- 0.051 0.99 0.99–1.00 0.15
LDL-cholesterol 0.99 0.98–0.99 0.01 0.98 0.97–0.99 0.03
HDL-cholesterol 1.00 0.98–1.02 0.83 1.00 0.98–1.03 0.77
BNP 1.006 1.00–1.00 < 0.01 1.00 0.99–1.00 0.27
Aspirin 1.22 0.70–2.09 0.47 0.54 0.27–1.06 0.07
Statin, 1.18 0.69–2.05 0.55 1.24 0.57–2.69 0.59
β-Blockers 2.17 1.05–5.28 0.04 2.00 0.82–5.74 0.13
Oral hypoglycemic agent 1.09 0.50–2.11 0.83 0.84 0.30–2.10 0.72
  1. MACE major adverse cardiovascular event, CI confidence interval, SAF skin autofluorescence, BMI body mass index, CABG coronary artery bypass graft, eGFR estimated glomerular filtration rate, HbA1c hemoglobin A1c, LDL low-density lipoprotein, HDL high-density lipoprotein, BNP brain natriuretic peptide